CHANGES IN THE INTERFERONAL STATUS INDICATORS IN PATIENTS OF THE LOCAL-DISTRIBUTED KIDNEY CANCER IN THE DYNAMICS OF THE DISEASE



Cite item

Full Text

Abstract

The aim of the research was to study the indicators of serum α- (IFN-α) and γ-interferon (IFN-γ), the levels of spontaneous and stimulated production of interferons by peripheral blood mononuclear cells in patients with locally advanced renal cell carcinoma (RCC) before and 14 days after the operation. Patients with RCC (T3 N0 M0) were examined before surgical treatment and 14 days after radical nephrectomy. The concentration of IFN-α and IFN-γ in serum was determined using enzyme-linked immunosorbent assay (ELISA). The level of spontaneous and stimulated (concanavalin A) production of IFN-α and IFN-γ was determined in the supernatants of peripheral blood mononuclear cells cultured for 72 hours by ELISA. It was found that in patients with locally advanced RCC, both before surgery and after surgical treatment, an increase in serum levels of IFN-α and IFN-γ was observed, and the spontaneous production of IFN-γ by peripheral blood mononuclear cells was also increased. 14 days after surgery there was a decrease in the spontaneous production of IFN-α in combination with an increased ability of peripheral blood mononuclear cells to induce the production of IFN-α and IFN-γ. The identified imbalance in the IFN-producing system in patients with RCC in the postoperative period must be considered when developing immunorehabilitation programs in this category of patients.

About the authors

L. M. Kurtasova

Krasnoyarsk State Medical University named after Prof. V. F. Voino-Yasenetsky

Author for correspondence.
Email: kurtasova.lm@mail.ru

PhD, MD, professor, professor of the department of clinical Immunology,

Krasnoyarsk

Russian Federation

R. A. Zukov

Krasnoyarsk State Medical University named after Prof. V. F. Voino-Yasenetsky

Email: fake@neicon.ru

PhD, MD, professor, head of the department of oncology and radiation therapy with PE course,

Krasnoyarsk

Russian Federation

A. A. Savchenko

Federal Research Center «Krasnoyarsk Science Center» of the Siberian Branch of the Russian Academy of Sciences, Scientifi c Research Institute of medical problems of the North

Email: fake@neicon.ru

PhD, MD, professor, head of the laboratory of cell molecular physiology and pathology, 

Krasnoyarsk

Russian Federation

N. A. Shakina

Krasnoyarsk Regional Center of AIDS prevention

Email: fake@neicon.ru

PhD, doctor of laboratory diagnostics of the department of immunological and hematological research,

Krasnoyarsk

Russian Federation

References

  1. Шубина И. Ж., Сергеев А. В., Мамедова Л. Т., Соколов Н. Ю., Кисельский М. В. Современные представления о противоопухолевом иммунитете. Российский биотерапевтический журнал 2015, 14(3), 19–28.
  2. Свитич О. А., Филина А. Б., Давыдова Н. В., Ганковская Л. В., Зверев В. В. Роль факторов врожденного иммунитета в процессе опухолеобразования. Медицинская иммунология 2018, 20(2), 151–162.
  3. Топтыгина А. П. Коингибирующие молекулы в норме и при патологии. Контрольные точки (checkpoint) иммунорегуляции. Часть 2. Участие коингибирующих молекул в развитии инфекционной и онкологической патологии. Моноклональные антитела – блокаторы контрольных точек. Российский иммунологический журнал 2018, 12(1), 3–16.
  4. Наровлянский А. Н., Ершов Ф. И., Гинцбург А. П. Интерфероны: перспективные направления исследований. Иммунология 2013, 3, 168–172.
  5. Верлан Н. В. Использование интерферонов: иммунологические и клинические аспекты. Цитокины и воспаление 2016, 15(1), 12–21.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2019 Kurtasova L.M., Zukov R.A., Savchenko A.A., Shakina N.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № 77 - 11525 от 04.01.2002.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies